Koncen Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 405

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 4

Koncen General Information

Description

Developer of medical technology intended to offer blood-purification. The company's technology helps to accelerate blood dialysis and blood purification adsorption, enabling healthcare providers to save the lives of the patients.

Contact Information

Website
www.koncen.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • No. 8 Shenzhou Street, Science City
  • High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510660
  • China
+86 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Koncen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 23-Jun-2022 000.00 Announced Generating Revenue
4. Secondary Transaction - Private 28-May-2019 00.000 000.00 Completed Generating Revenue
3. Later Stage VC 29-Mar-2018 000.00 Completed Generating Revenue
2. Later Stage VC 01-Jan-2013 $66.5K Completed Generating Revenue
1. Seed Round 18-Jul-2001 $66.5K $66.5K 00000 Completed Startup
To view Koncen’s complete valuation and funding history, request access »

Koncen Patents

Koncen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4074733-A1 Immunoglobulin binding protein, preparation method and application thereof Pending 06-Dec-2019 000000000
EP-4074733-A4 Immunoglobulin binding protein, preparation method and application thereof Pending 06-Dec-2019 000000000 0
EP-3919097-A1 Encapsulation structure of blood plasma adsorber and adsorbent thereof Pending 29-Jan-2019 00000000
EP-3919097-A4 Encapsulation structure of blood plasma adsorber and adsorbent thereof Pending 29-Jan-2019 A61M1/38 0

Koncen Executive Team (1)

Name Title Board Seat Contact Info
Xiaoyuan Chen Chairman & President
To view Koncen’s complete executive team members history, request access »

Koncen Board Members (1)

Name Representing Role Since
Xiaoyuan Chen Koncen Chairman & President 000 0000
To view Koncen’s complete board members history, request access »

Koncen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Koncen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
HongShan Venture Capital Minority 000 0000 000000 0
Hyfinity Investments Venture Capital Minority 000 0000 000000 0
Wens Investment (Guangdong) Corporate Venture Capital Minority 000 0000 000000 0
Guangzhou Financial Innovation Investment Venture Capital Minority 000 0000 000000 0
To view Koncen’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »